Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original
laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine.
Cardiovascular Revascularization
Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological
interventions, restenosis management, ... click here for full Aims & Scope
Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original
laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine.
Cardiovascular Revascularization
Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological
interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in
vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart
disease, cardiovascular surgery, congenital heart disease, coronary heart disease, epidemiology, genetics, health services and outcomes
research, invasive imaging, molecular cardiology, preventive cardiology, and vascular medicine.
Cardiovascular Revascularization
Medicine will consider all articles describing clinical trials and translational research (ie, those that unite the clinic with
the laboratory). The Journal publishes original articles, rapid communications, reviews, technical notes, teaching editorials, and special
features. Original articles that address any aspect of cardiovascular revascularization medicine are invited. Letters to the Editor and
interesting images are encouraged.
Hide Aims & Scope
